Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

Bextra's Risks Higher Than Vioxx

Not a surprise to find out Pfizer's Bextra, the drug that replaced Vioxx in late September as the current inflammatory of choice among conventional physicians, was just as problematic after a prominent cardiologist announced a pooled analysis of clinical trial results showed patients taking the drug were twice as likely to have a heart attack or stroke as those taking a placebo. In fact, an analysis of nearly 6,000 patients showed the risk of Bextra to be higher than Vioxx. Although...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports